Sheba Medical Center
New research gives a boost to the UK government's decision to delay the second dose of the Pfizer/BioNTech jab, but experts still urge caution.
By entering your email and clicking Sign Up, you're agreeing to let us send you customized marketing messages about us and our advertising partners. You are also agreeing to our Terms of Service and Privacy Policy.